TINAVI Medical

Beijing, China Founded: 2005 • Age: 21 yrs Listed
Minimally invasive robot-assisted systems for spinal surgeries are developed.

About TINAVI Medical

TINAVI Medical is a publicly listed company based in Beijing (China) founded in 2005. Minimally invasive robot-assisted systems for spinal surgeries are developed. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. Its focus areas include Life Sciences, Surgical Instruments, Robotic Surgery and High Tech.

Company details

TINAVI Medical is developing minimally invasive robot-assisted surgical systems and complementary products. The company is developing Phecda, a robot-assisted surgical system designed to be used in both open and minimally-invasive spinal surgeries. It reduces the amount of intraoperative X-rays by up to 90 with a margin of error of less than 0.8 mm. The device takes intraoperative 3D or 2D images which help surgeons create a surgical plan including screw selection and drill trajectory simulation. The company has not received FDA or CE Mark approval as of July 2017. The company has received a registration license from CFDA.

  • Headquarters Beijing, China
  • Stage Public
  • Sectors
    Healthcare
    Industrial Goods & Manufacturing
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website tinavi.com
  • Social LinkedIn
  • Legal Name Tinavi Medical Technologies Co., Ltd. Class A
Key Metrics
  • Annual Revenue
    $39.83 M (USD)
    55.88
    as on Dec 31, 2025
  • Net Profit
    -$26.1 M (USD)
    -50.87
    as on Dec 31, 2025
  • EBITDA
    -$18.68 M (USD)
    -13.71
    as on Dec 31, 2025

IPO & Listings of TINAVI Medical

TINAVI Medical is a publicly listed company on the SSE with ticker symbol 688277 in China, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date07 Jul 2020
  • Listed onSSE: 688277
  • Listed entityTinavi Medical Technologies Co., Ltd. Class A
  • Exchange sectorHealth technology
  • ISINCNE100004256
  • Share price14.07 CNY (-3.03% on the day) · 2026-10-14
  • Market capitalisation6,768,114,949.00 CNY
  • EPS (diluted, trailing year)-0.43 CNY
  • Volume (last session)3,714,685

Financials of TINAVI Medical

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025278.8M CNY-182.8M CNY-130.8M CNY
2024178.9M CNY-121.1M CNY-115.0M CNY
2023209.2M CNY-156.4M CNY-167.1M CNY
2022155.8M CNY-110.6M CNY-124.7M CNY
2021154.8M CNY-79.9M CNY-99.2M CNY
Premium access

Detailed financial statements for TINAVI Medical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Tinavi Medical

Premium access

Complete news archive for TINAVI Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about TINAVI Medical

TINAVI Medical was founded in 2005.

TINAVI Medical is headquartered in Beijing, China.

Annual revenue of TINAVI Medical is $39.83M as on Dec 31, 2025.

TINAVI Medical is developing minimally invasive robot-assisted surgical systems and complementary products. The company is developing Phecda, a robot-assisted surgical system designed to be used in both open and minimally-invasive spinal surgeries. It reduces the amount of intraoperative X-rays by up to 90 with a margin of error of less than 0.8 mm. The device takes intraoperative 3D or 2D images which help surgeons create a surgical plan including screw selection and drill trajectory simulation. The company has not received FDA or CE Mark approval as of July 2017. The company has received a registration license from CFDA.

Yes, TINAVI Medical is publicly traded on SSE under the ticker symbol 688277.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available